G Niebch

Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane

T. Schilling, K. B. Keppler, Manfred Heim et al. · Investigational New Drugs · 1995 · 146 citations

Medicinal Chemistry, Pharmacology, Pharmacokinetic Trial +2

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

Róbert Hermann, G Niebch, Harald O. Borbe et al. · European Journal of Pharmaceutical Sciences · 1996 · 110 citations

Pharmaceutical Science, Biochemistry, Healthy Volunteers +6

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

Ingrid Duijkers, Christine Klipping, Wim N.P. Willemsen et al. · Human Reproduction · 1998 · 109 citations · Full text

Hormonal Contraceptive, Fertility, Reproductive Health +18

Dose-proportionality of oral thioctic acid — coincidence of assessments via pooled plasma and individual data

Kerstin Breithaupt‐Grögler, G Niebch, Edith Schneider et al. · European Journal of Pharmaceutical Sciences · 1999 · 96 citations

Medicine, Pharmacotherapy, Dosimetry +5

Phase I Trial of 6-Hour Infusion of Glufosfamide, a New Alkylating Agent With Potentially Enhanced Selectivity for Tumors That Overexpress Transmembrane Glucose Transporters: A Study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group

Evangelos Briasoulis, Ian Judson, Nicholas Pavlidis et al. · Journal of Clinical Oncology · 2000 · 60 citations